|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Sigilon Therapeutics, Inc. (SGTX) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
31,240,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Sigilon Therapeutics is a clinical stage biotechnology company developing a class of therapeutics and functional cures for patients with chronic diseases. Co.'s product candidates include: SIG-005, which treats the non-neurological manifestations of mucopolysaccharidosis type 1 in patients with the disease; SIG-007, which provides continuous and prolonged release of functional enzyme at levels sufficient to produce clinical benefits and alleviate progression of the downstream aspects of Fabry disease; SIG-002, which is designed to replace islet cells for the treatment of Type 1 Diabetes; and SIG-001, which prevents bleeding episodes in patients with moderate to severe Hemophilia A.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
1,718,493 |
1,718,493 |
| Total Buy Value |
$0 |
$0 |
$25,639,916 |
$25,639,916 |
| Total People Bought |
0 |
0 |
1 |
1 |
| Total Buy Transactions |
0 |
0 |
1 |
1 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Afeyan Noubar |
10% Owner |
– – • |
2023-08-11 |
4 |
D |
$14.92 |
$11,901,982 |
I/I |
(797,720) |
0 |
|
- |
|
| Shenandoah Acquisition Corp |
10% Owner |
– – • |
2023-08-11 |
4 |
B |
$14.92 |
$25,639,916 |
D/D |
1,718,493 |
100 |
2.45 |
- |
|
| Cox John |
|
– • – |
2023-08-11 |
4 |
D |
$0.00 |
$0 |
D/D |
(341) |
0 |
|
- |
|
| Yuan Qing Sarah |
CTOO |
• – – |
2023-08-11 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,884) |
0 |
|
- |
|
| Pontes Josias |
CHIEF FINANCIAL OFFICER |
• – – |
2023-08-11 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,504) |
0 |
|
- |
|
| Vivaldi Coelho Rogerio |
PRESIDENT AND CEO |
• • – |
2023-08-11 |
4 |
D |
$0.00 |
$0 |
D/D |
(12,169) |
0 |
|
- |
|
| Kowalsky Matthew Paul |
CHIEF OF STAFF AND CLO |
• – – |
2023-08-11 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,925) |
0 |
|
- |
|
| Yuan Qing Sarah |
CTOO |
• – – |
2023-07-27 |
4 |
OE |
$19.24 |
$55,488 |
D/D |
2,884 |
2,884 |
|
- |
|
| Pontes Josias |
CHIEF FINANCIAL OFFICER |
• – – |
2023-07-21 |
4 |
OE |
$19.24 |
$27,783 |
D/D |
1,444 |
3,254 |
|
- |
|
| Vivaldi Coelho Rogerio |
PRESIDENT AND CEO |
• • – |
2023-07-21 |
4 |
OE |
$19.24 |
$106,359 |
D/D |
5,528 |
11,963 |
|
- |
|
| Shenandoah Acquisition Corp |
10% Owner |
– – • |
2023-06-28 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
211,110 |
|
- |
|
| Kowalsky Matthew Paul |
CHIEF OF STAFF AND CLO |
• – – |
2023-02-28 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
19,683 |
|
- |
|
| Vivaldi Coelho Rogerio |
PRESIDENT AND CEO |
• • – |
2021-11-04 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
73,461 |
|
- |
|
| Pontes Josias |
VP, HEAD OF FINANCE |
• – – |
2021-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
11,500 |
13,339 |
|
- |
|
| Ruffolo Robert R |
|
– • – |
2021-07-01 |
4 |
AS |
$10.36 |
$69,930 |
D/D |
(6,750) |
0 |
|
- |
|
| Ruffolo Robert R |
|
– • – |
2021-07-01 |
4 |
OE |
$0.57 |
$3,848 |
D/D |
6,750 |
6,750 |
|
- |
|
| Pontes Josias |
VP, Head of Finance |
• – – |
2021-06-14 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
600 |
|
- |
|
| Anderson Daniel Griffith |
|
– • – |
2021-06-02 |
4 |
S |
$10.00 |
$2,000,000 |
D/D |
(200,000) |
2,022,222 |
|
- |
|
| Lilly Eli & Co |
10% Owner |
– – • |
2020-12-08 |
4 |
B |
$18.00 |
$5,400,000 |
D/D |
300,000 |
2,744,443 |
2.45 |
- |
|
| Lilly Eli & Co |
10% Owner |
– – • |
2020-12-08 |
4 |
A |
$0.00 |
$0 |
D/D |
2,444,443 |
2,444,443 |
|
- |
|
| Cox John |
Director |
– • – |
2020-12-08 |
4 |
A |
$0.00 |
$0 |
I/I |
4,444 |
4,444 |
|
- |
|
| Vivaldi Coelho Rogerio |
President and CEO |
• • – |
2020-12-08 |
4 |
A |
$0.00 |
$0 |
D/D |
22,222 |
22,222 |
|
- |
|
| Afeyan Noubar |
10% Owner |
– – • |
2020-12-08 |
4 |
A |
$0.00 |
$0 |
I/I |
10,370,369 |
1,481,481 |
|
- |
|
| Anderson Daniel Griffith |
Director |
– • – |
2020-12-03 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,222,222 |
|
- |
|
24 Records found
|
1
|
Page 1 of 1 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
